Lars Fruergaard Jørgensen, Novo Nordisk CEO (Graeme Sloan/Sipa USA)(Sipa via AP Images)
Novo Nordisk to decrease some insulin pen manufacturing, transition supply
Novo Nordisk has told government and global nonprofits that it plans to significantly downsize its manufacturing of some of its older insulin pens, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.